ReShape Lifesciences Inc.

-0.03 (-1.48%)
Earnings Announcements

ReShape Lifesciences Reports Qtrly Loss Per Share $1.48

Published: 11/11/2021 13:47 GMT
ReShape Lifesciences Inc. (RSLS) - Reshape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results.
Reshape Lifesciences - Qtrly Revenue Was $3.7 Million Versus $3.6 Million for Three Months Ended September 30, 2020.
Q3 Revenue Was $3.7 Million Compared to $3.6 Million in Revenue for Q3 2020.
Qtrly Loss per Share $1.48.
Revenue is expected to be $3.89 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $4.45 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.